Physician profile
Steven Solik
NPI 1700807468
$1,496.58
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $235 · 2021: $455.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $481.68 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $263.67 | 2019-2020 | |
| Abbvie INC. | $165.53 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.05 | 2019 | |
| Ferring Pharmaceuticals INC. | $81.92 | 2019-2021 | |
| Ucb, INC. | $80.31 | 2019 | |
| Merck Sharp & Dohme LLC | $45.67 | 2019-2021 | |
| Redhill Biopharma INC. | $39.17 | 2020 | |
| Janssen Pharmaceuticals, INC | $34.96 | 2019 | |
| Allergan, INC. | $34.32 | 2019 | |
| Ironwood Pharmaceuticals, INC | $32.67 | 2019 | |
| Intercept Pharmaceuticals, INC. | $30.87 | 2019-2020 | |
| Gilead Sciences, INC. | $27.67 | 2019 | |
| Qol Medical, LLC | $24.60 | 2019 | |
| Celgene Corporation | $14.91 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $11.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Solik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.